AKBA logo

AKBA

Akebia Therapeutics, Inc.NASDAQHealthcare
$1.38-2.13%ClosedMarket Cap: $369.7M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-02-25BTIGBuy
2026-02-06Piper SandlerOverweight
2026-02-06HC Wainwright & Co.Buy
2025-12-02BTIGBuy
2025-12-02HC Wainwright & Co.Buy
2025-10-30HC Wainwright & Co.Buy
2025-10-29BTIGBuy
2025-04-04HC Wainwright & Co.Buy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Fri Dec 31$-0.14$192.9M3
Sun Dec 31$0.07$252.3M4
Mon Dec 31$0.26$312.7M2
Tue Dec 31$0.64$424.1M2